Trial results show immunotherapy & targeted drugs could stop melanomas returning

Some of the treatments currently used for certain advanced melanomas could be effective in those with an earlier stage of disease after surgery, according to results from two clinical trials. The studies (Checkmate 238 and COMBI-AD) examined an immunotherapy drug and a combination of targeted drugs respectively, the results showed that both types of treatment

Continue Reading

Scottish Medicines Consortium blocks access to Actelion’s PAH drug on NHS Scotland

Actelion says it is disappointed by the decision made by Scottish cost regulators to refuse NHS funding for pulmonary arterial hypertension drug Uptravi. The Scottish Medicines Consortium (SMC) issued guidance not recommending use of Uptravi (selexipag) for a sub-population of adult patients with the potentially life-threatening condition, which leads to an increase in blood pressure

Continue Reading